GlassScriptPhysician profile
Jean Frederick Botha
NPI 1982661344
$7,819.65
in general payments reported to CMS, 2019-2025
8 companies · $3,867 in 2025
The $3,867 reported for 2025 was more than what 82% of Transplant Surgery providers received nationally (typical 2025 total: $423).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $577 · 2024: $3,376 · 2025: $3,867.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,251 · Honoraria: $1,600 · Food and Beverage: $968.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,251.41 |
| Honoraria | $1,600.00 |
| Food and Beverage | $968.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Transmedics, INC. | $3,623.18 | 2023-2024 | Organ Care System |
| Organox LTD | $2,093.60 | 2023-2025 | Metra |
| Paragonix Technologies, INC. | $1,812.75 | 2024-2025 | Liverguard, Baroguard, Lungguard |
| Xvivo Perfusion INC. | $215.88 | 2025 | Xvivo Perfusion System (Xps) |
| Intuitive Surgical, INC. | $28.79 | 2023-2024 | Da Vinci Surgical System |
| Medtronic, INC. | $15.36 | 2023 | Signia |
| Ethicon US, LLC | $15.26 | 2023 | Echelon Flex |
| Organ Recovery Systems, INC. | $14.83 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jean Botha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.